There is an increasing need to both publish and find reliable information with reproducible knowledge, which can be translated into practice.
We, a group of professionals and lead scientists, decided to create our own scientists-led non-profit publishing company and founded Andover House Inc., in January 2018.
We are registered as a 501(c)3not-for-profit publisher in the Commonwealth of Massachusetts, USA (EIN:82-4239886).
Our objective is to disseminate peer-reviewed scientific reports and individual articles online in academic journals that are open to the scientific community and accessible by the public without additional charge to readers and libraries.
Our mission is to further the progress of science, engineering, and technology in medicine and promote all progressive and rational aspects of nanomedicine from basic science through commercialization while exercising good publishing practice.
The publisher is governed by the Board of Directors which oversees operations, approves the annual budget, and sets strategic goals for the organization. We are supported by the European Foundation for Clinical Nanomedicine (CLINAM.org), the International Society for Nanomedicine (https://www.clinam.org/eur-int-society-for-nanomedicine.html) and by the European Society for Nanomedicine (http://www.esnam.org).
We are signatories to the San Francisco Declaration on Research Assessment (DORA) and support its aims to improve how the quality of research is evaluated. Bibliometrics can be used as indicators of general interest and trends, but simple numbers do not replace your own critical evaluation of an article and certainly cannot indicate the value of research or of any individual.
For more information please contact our office.
Andover House, Inc.
138 River Rd. Ste 107
Andover, MA 01810, USA